Afuco™ Anti-CA9 ADCC Therapeutic Antibody (Girentuximab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric antibody to Human CA9.
Supplier Creative Biolabs
Product # AFC-TAB-H43
Pricing Inquiry
Host Chimeric
Target CA9
Species Reactivity Human
Type ADCC enhanced antibody
Applications ELISA, FC, IP, FuncS, IF, Neut
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback